Cancer
📧 Sign up to get email alerts when something new happens for Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-09Clinical Trial Update: The Efficacy of Intravenous Iron for the Treatment of Anemia in Cancer Patients [Phase 2]
The document provides an update on a Phase 2 trial evaluating intravenous iron for treating anemia in cancer patients, focusing on efficacy.…
-
CLINICAL_TRIALS trial_result · 2017-02-07Clinical Trial Update: Recombinant Human Hyaluronidase in Treating Lymphedema in Patients With Cancer [Phase 1, Phase 2]
This update covers a Phase 1/2 study of recombinant human hyaluronidase for lymphedema in cancer patients. The trial was terminated and resu…
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Study of IMC-11F8 in Participants With Advanced Solid Tumors [Phase 1]
A Phase 1 study of IMC-11F8 in participants with advanced solid tumors has completed, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-02-03Clinical Trial Update: Apoyo Con Carino: Patient Navigation for Palliative Care [NA]
The trial update notes the completed status of the Apoyo Con Carino study evaluating patient navigation for palliative cancer care, sponsore…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Oxcarbazepine Plus Morphine in Patients With Refractory Cancer Pain [Phase 1]
A Phase 1 trial evaluating oxcarbazepine in combination with morphine for refractory cancer pain; the study status is TERMINATED.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-01-27Clinical Trial Update: A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin [Phase 1]
Phase 1 study of RO5479599 alone or with cetuximab or erlotinib in patients with metastatic or locally advanced HER3-expressing solid tumors…
-
CLINICAL_TRIALS trial_result · 2017-01-26Clinical Trial Update: Evaluating the Effectiveness of Art Therapy on Mood, Anxiety, and Pain Levels in Cancer Patients [NA]
A completed clinical trial assessed whether art therapy improves mood, anxiety, and pain in cancer patients.
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: Low Dose Chemotherapy Versus Best Supportive Care in Progressive Pediatric Malignancies [Phase 3]
This Phase 3 trial compared low-dose chemotherapy to best supportive care in children with progressive malignant tumors. The study status is…
-
CLINICAL_TRIALS trial_result · 2017-01-25Clinical Trial Update: A Study Of PF-04554878 In Patients With Advanced Non-Hematologic Malignancies [Phase 1]
Phase 1 study of PF-04554878 in patients with advanced non-hematologic malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-24Clinical Trial Update: Phase I Study of LB-100 With Docetaxel in Solid Tumors [Phase 1]
A Phase I study evaluating LB-100 in combination with docetaxel for solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-20Clinical Trial Update: Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant [Phase 2]
Phase 2 trial investigating antithymocyte globulin, clofarabine, and rituximab after unsuccessful stem cell transplant; study terminated wit…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Computerized Questionnaires in Assessing Symptoms, Pain, Depression, and Physical Function in Patients With Metastatic and/or Advanced Locoregional Cancer
This completed clinical trial evaluated the use of computerized questionnaires to assess symptoms, pain, depression, and physical function i…
-
CLINICAL_TRIALS trial_result · 2017-01-18Clinical Trial Update: Cohort Study to Identify Cancer Patients at High Risk of Venous Thromboembolism
This completed cohort study investigates identifying cancer patients at high risk of venous thromboembolism, with emphasis on deep vein thro…
-
CLINICAL_TRIALS trial_result · 2017-01-13Clinical Trial Update: Effectiveness of an Adventure-based Training Programme to Reduce Fatigue for Childhood Cancer Survivors [NA]
Completed clinical trial evaluating the effectiveness of an adventure-based training programme to reduce fatigue in childhood cancer survivo…
-
CLINICAL_TRIALS trial_result · 2017-01-12Clinical Trial Update: Percutaneous Cryoablation in Treating Patients With Painful Bone Metastases [NA]
This trial update reports the completion of a Mayo Clinic-sponsored study evaluating percutaneous cryoablation for pain relief in patients w…
-
CLINICAL_TRIALS trial_result · 2017-01-11Clinical Trial Update: Treatment Algorithm for Nausea and Vomiting in the Palliative Phase [Phase 4]
Phase 4 trial update presenting an algorithm for treating nausea and vomiting in patients with cancer in the palliative phase.
-
CLINICAL_TRIALS trial_result · 2017-01-10Clinical Trial Update: Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.
Takeda-sponsored cohort study assessed cancer incidence among people with type 2 diabetes treated with pioglitazone; results were posted in …
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer [Phase 4]
A Phase 4 trial evaluating rivaroxaban to prevent venous thromboembolism in Asian patients with cancer has completed.
-
CLINICAL_TRIALS trial_result · 2017-01-09Clinical Trial Update: Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating the maximum tolerated dose of BAY1000394 given on a 3 days on / 4 days off schedule in subjects with advanced mal…
-
CLINICAL_TRIALS trial_result · 2017-01-05Clinical Trial Update: Patient Outcomes of a Self-care Management Approach to Cancer Symptoms: A Clinical Trial [NA]
This document reports on a completed clinical trial evaluating a self-care management approach to cancer symptoms and its effect on patient …
-
CLINICAL_TRIALS trial_result · 2017-01-04Clinical Trial Update: Spironolactone Administration to Prevent Ischemic Kidney Injury in Critically Ill Cancer Patients [Phase 2, Phase 3]
Clinical trial update on using spironolactone to prevent ischemic kidney injury in critically ill cancer patients, with Phase 2 and Phase 3 …
-
CLINICAL_TRIALS trial_result · 2016-12-30Clinical Trial Update: The Sakakibara Health Integrative Profile Cohort Study
This document notes the completion of the Sakakibara Health Integrative Profile Cohort Study sponsored by the Sakakibara Heart Institute, fo…
-
CLINICAL_TRIALS trial_result · 2016-12-29Clinical Trial Update: Phase 2 Safety, Tolerability and Efficacy Study of CPI-613 in Cancer Patients [Phase 2]
The update indicates that the Phase 2 safety, tolerability, and efficacy study of CPI-613 in cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: APF530 or Aloxi (Palonosetron Hydrochloride) Combined With Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer [Phase 3]
Phase 3 trial evaluating APF530 or Aloxi (palonosetron hydrochloride) in combination with dexamethasone to prevent chemotherapy-induced naus…
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Phase I Dose Escalation Study With an Allosteric AKT 1/2 Inhibitor in Patients [Phase 1]
Completed Phase I dose-escalation trial of an allosteric AKT 1/2 inhibitor sponsored by Bayer in patients with cancer.